NASDAQ : IMRX

Immuneering Corporation

$4.64 USD

-$0.14 (-2.93%)

Volume
1.43M
Average Volume
1.54M
Market Capitalization
$168.44M
P/E Ratio
-3.97
Dividend Yield
0.00%
Price Target
$14.50
Year High
$10.08
Year Low
$2.90
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$32.45
3333332"{? p/.m7yd f,0=

Annual earnings financials

IMRX financial data with annual/quarterly toggle

IMRX GAAP EPS - Annual & Quarterly

IMRX Sales Revenue - Annual & Quarterly

IMRX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

IMRX Estimated and Actual Revenue by Quarter
IMRX Estimated and Actual EPS by Quarter
IMRX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
IMRX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -17.82M -17.82M -17.82M - - -
2027-09-30 0 -17.16M -17.16M -17.16M - - -
2027-06-30 0 -16.06M -16.06M -16.06M - - -
2027-03-31 0 -14.3M -14.3M -14.3M - - -
2026-12-31 0 -14.62M -14.62M -14.62M - - -
2026-09-30 0 -15.24M -11.66M -13.45M - - -
IMRX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 2 -0.405 -0.405 -0.405
2027-09-30 0 - - - 1 -0.39 -0.39 -0.39
2027-06-30 0 - - - 1 -0.365 -0.365 -0.365
2027-03-31 0 - - - 2 -0.325 -0.325 -0.325
2026-12-31 0 - - - 2 -0.33217 -0.33217 -0.33217
2026-09-30 0 - - - 4 -0.34631 -0.26483 -0.30557